» Articles » PMID: 35752273

Mutation of the α5 Nicotinic Acetylcholine Receptor Subunit Increases Ethanol and Nicotine Consumption in Adolescence and Impacts Adult Drug Consumption

Overview
Specialties Neurology
Pharmacology
Date 2022 Jun 25
PMID 35752273
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol and nicotine are commonly used during adolescence, establishing long-lasting neuroplastic alterations that influence subsequent drug use and abuse. Drinking- and smoking-related traits have been extensively associated with variation in CHRNA5 - the gene that encodes the α5 subunit of neuronal nicotinic acetylcholine receptors (nAChRs). The single nucleotide polymorphism (SNP) rs16969968 in CHRNA5 encodes an amino acid substitution (D398N) that alters the function and pharmacokinetics of α5-containing nAChR. When expressed in rodents, this variant results in increased ethanol and nicotine operant self-administration. How disruption of α5-containing nAChRs influences adolescent ethanol and nicotine intake, and how it modulates interactions between these drugs has not been previously explored. In the present study, we examined volitional ethanol and nicotine consumption in adolescent mice (post-natal day 30-43) of both sexes with mutated (SNP) or lacking (KO) the α5 nAChR subunit. The effect of adolescent alcohol or nicotine exposure on home cage consumption of the opposite drug in adulthood and its modulation by Chrna5 mutation and sex were examined. During adolescence, we found that α5 nAChR disruption increases nicotine intake in mice of both sexes, but the effect on alcohol intake was only observed in females. The sex-specific increase in alcohol consumption in α5 SNP and KO was replicated in adulthood. The effect of adolescent alcohol or nicotine exposure on subsequent intake of the opposite drug in adulthood is modulated by sex and Chrna5 mutation. These observations suggest sex differences in the genetic architecture of alcohol dependence, and modulators of alcohol and nicotine interactions.

Citing Articles

Distinct Chrna5 mutations link excessive alcohol use to types I/II vulnerability profiles and IPN GABAergic neurons.

Tochon L, Henkous N, Besson M, Maskos U, David V Transl Psychiatry. 2024; 14(1):461.

PMID: 39505853 PMC: 11541707. DOI: 10.1038/s41398-024-03164-8.


Smoking-Related Increases in Alcohol Outcomes and Preliminary Evidence for the Protective Effect of a Functional Nicotine Receptor Gene (CHRNA5) Variant on Alcohol Consumption in Individuals Without Alcohol Use Disorder.

Venkatesh S, Stangl B, Yan J, Carde N, Stein E, Diazgranados N Int J Neuropsychopharmacol. 2024; 27(10).

PMID: 39208422 PMC: 11450629. DOI: 10.1093/ijnp/pyae035.


Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.

Nagori K, Pradhan M, Sharma M, Ajazuddin , Badwaik H, Nakhate K Curr Alzheimer Res. 2024; 21(1):50-68.

PMID: 38529600 DOI: 10.2174/0115672050306008240321034006.


Investigating the role of nicotinic acetylcholine receptors in menthol's effects in mice.

Akinola L, Gonzales J, Buzzi B, Mathews H, Papke R, Stitzel J Drug Alcohol Depend. 2024; 257:111262.

PMID: 38492255 PMC: 11031278. DOI: 10.1016/j.drugalcdep.2024.111262.


The role of nicotinic receptors in alcohol consumption.

Kamens H, Flarend G, Horton W Pharmacol Res. 2023; 190:106705.

PMID: 36813094 PMC: 10083870. DOI: 10.1016/j.phrs.2023.106705.

References
1.
Dierker L, Selya A, Piasecki T, Rose J, Mermelstein R . Alcohol problems as a signal for sensitivity to nicotine dependence and future smoking. Drug Alcohol Depend. 2013; 132(3):688-93. PMC: 3770797. DOI: 10.1016/j.drugalcdep.2013.03.018. View

2.
Chaarani B, Kan K, Mackey S, Spechler P, Potter A, Orr C . Low Smoking Exposure, the Adolescent Brain, and the Modulating Role of CHRNA5 Polymorphisms. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019; 4(7):672-679. PMC: 6709448. DOI: 10.1016/j.bpsc.2019.02.006. View

3.
Hong L, Hodgkinson C, Yang Y, Sampath H, Ross T, Buchholz B . A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proc Natl Acad Sci U S A. 2010; 107(30):13509-14. PMC: 2922167. DOI: 10.1073/pnas.1004745107. View

4.
Gotti C, Zoli M, Clementi F . Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci. 2006; 27(9):482-91. DOI: 10.1016/j.tips.2006.07.004. View

5.
ONeill H, Wageman C, Sherman S, Grady S, Marks M, Stitzel J . The interaction of the Chrna5 D398N variant with developmental nicotine exposure. Genes Brain Behav. 2018; 17(7):e12474. PMC: 7313682. DOI: 10.1111/gbb.12474. View